Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001144204-17-002333)

Filing Details

Accession Number:
0001144204-17-002333
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-17 09:54:54
Reporting Period:
2017-01-13
Filing Date:
2017-01-17
Accepted Time:
2017-01-17 09:54:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT Metal Mining (1000) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553236 Kevin Pollack C/O Opiant Pharmaceuticals, Inc.
401 Wilshire Blvd., 12Th Floor
Santa Monica CA 90401		 See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-13 4,820 $6.98 4,820 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.26 to $7.05, inclusive.